Affimed to Present at the Cowen and Company 36th Annual Health Care Conference
HEIDELBERG, Germany, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Florian Fischer, CFO, will …